How does Urocit®-K work?
The potassium citrate in Urocit®-K works partly by restoring the naturally occurring chemicals that block the formation of stones.
Urocit®-K normalizes the urinary environment so that calcium stone formation is inhibited.
Urocit®-K also reduces the tendency for uric acid stone formation by alkalinizing the urine. Many patients with this type of stone cease to form new stones when taking Urocit®-K. In those who still form stones, the stones develop at a lower rate than before treatment.
The wax matrix system
Urocit®-K contains potassium citrate in a wax-matrix tablet. This wax-matrix system delivers an extended release of medication which allows for less frequent dosing — once in the morning and once at night, or as prescribed by your physician.
Also, the slow-release tablets are better tolerated than liquid preparations so there is less stomach upset.
The wax-matrix tablets, unlike powder forms, offer the added convenience of not having to be reconstituted with water. And, there are no bottles of liquid to break or spill.
StoneDisease.org
Information about the causes, symptoms, diagnosis, and treatment of stone disease Website»
Thiola® (tiopronin)
For the prevention of cystine kidney stone formation
Website»
Lithostat® (acetohydroxamic acid)
Adjunctive therapy in patients with chronic urea-splitting urinary infection
Website»
